1. Home
  2. ATOS vs CRGO Comparison

ATOS vs CRGO Comparison

Compare ATOS & CRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATOS
  • CRGO
  • Stock Information
  • Founded
  • ATOS 2009
  • CRGO 2012
  • Country
  • ATOS United States
  • CRGO Israel
  • Employees
  • ATOS N/A
  • CRGO N/A
  • Industry
  • ATOS Biotechnology: Pharmaceutical Preparations
  • CRGO Blank Checks
  • Sector
  • ATOS Health Care
  • CRGO Finance
  • Exchange
  • ATOS Nasdaq
  • CRGO Nasdaq
  • Market Cap
  • ATOS 114.5M
  • CRGO 106.1M
  • IPO Year
  • ATOS 2012
  • CRGO N/A
  • Fundamental
  • Price
  • ATOS $0.80
  • CRGO $4.06
  • Analyst Decision
  • ATOS Strong Buy
  • CRGO Strong Buy
  • Analyst Count
  • ATOS 3
  • CRGO 2
  • Target Price
  • ATOS $7.00
  • CRGO $4.75
  • AVG Volume (30 Days)
  • ATOS 678.1K
  • CRGO 94.4K
  • Earning Date
  • ATOS 03-31-2025
  • CRGO 02-24-2025
  • Dividend Yield
  • ATOS N/A
  • CRGO N/A
  • EPS Growth
  • ATOS N/A
  • CRGO N/A
  • EPS
  • ATOS N/A
  • CRGO N/A
  • Revenue
  • ATOS N/A
  • CRGO $22,456,000.00
  • Revenue This Year
  • ATOS N/A
  • CRGO $18.98
  • Revenue Next Year
  • ATOS N/A
  • CRGO $27.78
  • P/E Ratio
  • ATOS N/A
  • CRGO N/A
  • Revenue Growth
  • ATOS N/A
  • CRGO 13.00
  • 52 Week Low
  • ATOS $0.72
  • CRGO $1.27
  • 52 Week High
  • ATOS $2.31
  • CRGO $4.42
  • Technical
  • Relative Strength Index (RSI)
  • ATOS 41.00
  • CRGO 59.98
  • Support Level
  • ATOS $0.79
  • CRGO $3.85
  • Resistance Level
  • ATOS $0.89
  • CRGO $4.25
  • Average True Range (ATR)
  • ATOS 0.05
  • CRGO 0.28
  • MACD
  • ATOS 0.01
  • CRGO -0.03
  • Stochastic Oscillator
  • ATOS 25.14
  • CRGO 68.75

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

About CRGO Freightos Limited Ordinary shares

Freightos Ltd operates as a vendor-neutral booking and payment platform for international freight. Its platform supports supply chain efficiency and agility by enabling real-time procurement of ocean and air shipping across more than ten thousand importers/exporters. forwarders, and dozens of airlines and ocean carriers. WebCargo by Freightos is a freight platform connecting carriers and forwarders in particular an air cargo eBooking platform. Freightos.com is a digital international freight marketplace for importers and exporters for instant pricing, booking, and shipment management. The company operates in two segments-Platform segment and Solutions segment. Geographically, the company operates in Europe, Hong Kong, United States which is majority revenue generator and others.

Share on Social Networks: